A phase II study of fenretinide in patients with hormone refractory prostate cancer: a trial of the Cancer Therapeutics Research Group
Publication in refereed journal

香港中文大學研究人員

引用次數
替代計量分析
.

其它資訊
摘要Purpose Fenretinide is a synthetic retinoid with activity in prostate cancer and other cell lines. The aim of this study was to assess the efficacy and tolerability of fenretinide in chemotherapy-na < ve men with hormone refractory prostate cancer.
著者Moore MM, Stockler M, Lim R, Mok TSK, Millward M, Boyer MJ
期刊名稱Cancer Chemotherapy and Pharmacology
出版年份2010
月份10
日期1
卷號66
期次5
出版社SPRINGER
頁次845 - 850
國際標準期刊號0344-5704
電子國際標準期刊號1432-0843
語言英式英語
關鍵詞Fenretinide; Hormone refractory; Prostate cancer
Web of Science 學科類別Oncology; ONCOLOGY; Pharmacology & Pharmacy; PHARMACOLOGY & PHARMACY

上次更新時間 2020-17-10 於 00:10